Advancing Genetic Research with LTE Scientific Autoclave at Oxford Science Park

Nucleome Therapeutics, a prominent UK biotech company, is at the forefront of decoding the dark matter of the human genome to develop innovative precision medicines.

Their mission focuses on the non-coding regions of DNA, unlocking new potential for drug discovery and development for autoimmune diseases such as multiple sclerosis, lupus, and rheumatoid arthritis.

Starting within Oxford University’s BioEscalator incubator, the BioEscalator, Nucleome Therapeutics has rapidly expanded, thanks to significant investments from notable entities like Oxford Science Enterprises, M Ventures, Pfizer Ventures, and Johnson & Johnson Innovation.

Relocation and Equipment Needs
During their move from Oxford’s Old Road Campus to the Schrodinger Building at Oxford Science Park, Nucleome Therapeutics required a dependable laboratory autoclave to support their cutting-edge genetic research. LTE Scientific, a trusted name in the UK for autoclave manufacturing, was selected for this crucial project.

Project Implementation
Collaborating closely LTE’s Sales Manager, Anthony Campbell-Carr and Nucleome Therapeutic’s Director of Facilities, Paul Brackstone worked together from identifying the autoclave requirements up to its installation. Anthony conducted several site visits to ensure a seamless installation process.
The research autoclave was essential to the facility achieving Containment Level 2 for handling and disposing of biological materials and has helped to eliminate the high costs of external waste disposal.

Installation Challenges and Solutions
The installation of the Touchclave-LAB 200K model K200KE3AB faced a unique challenge due to the small lift in the Schrodinger Building, originally designed as an office space. The LTE team addressed this by disassembling the autoclave for transport and reassembling it on-site.

Despite this logistical hurdle, the installation was completed smoothly and on schedule. The Touchclave-LAB 200K, known for its ease of use and versatility, has proven to be highly efficient for Nucleome Therapeutics' needs, enhancing their waste control procedures even allowing for the sterilization of lab coats effectively without damage.

Enhanced Operational Efficiency
Paul Brackstone highlighted the autoclave’s performance, quoting “The user function is great, and the cycle times are much better compared to previous equipment I’ve used. It has enhanced our health and safety procedures for waste control and helped us to achieve time efficiencies.” The new autoclave has also reduced dependency on commercial cleaning services and environmentally harmful disinfecting chemicals.

Outstanding Customer Support
Nucleome Therapeutics has praised LTE Scientific’s comprehensive customer support, from initial site inspections to ongoing maintenance. The proactive approach, including site visits and timely responses to any issues, ensured a smooth installation process and continued operational efficiency.

Anthony Campbell-Carr quoted “"Customer support is a cornerstone of our service. We believe in thorough site visits and ensuring that our customers have the equipment they need within the right timeframe. Our consultative approach, flexibility and high-quality equipment are key aspects of what sets LTE apart."

Conclusion
The partnership between Nucleome Therapeutics and LTE Scientific showcases the importance of tailored solutions and excellent customer support in advancing scientific research. The Touchclave-LAB 200K has not only met but exceeded the expectations, contributing significantly to the operational success of Nucleome Therapeutics.

For more information on how LTE Scientific can support your laboratory equipment needs, visit our website.